TrialClinical breast cancer2016

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.

Jennifer A Crozier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.